PT3235494T - Preparação transdérmica contendo donepezilo como ingrediente ativo - Google Patents

Preparação transdérmica contendo donepezilo como ingrediente ativo

Info

Publication number
PT3235494T
PT3235494T PT158703652T PT15870365T PT3235494T PT 3235494 T PT3235494 T PT 3235494T PT 158703652 T PT158703652 T PT 158703652T PT 15870365 T PT15870365 T PT 15870365T PT 3235494 T PT3235494 T PT 3235494T
Authority
PT
Portugal
Prior art keywords
active ingredient
preparation containing
transdermal preparation
containing donepezil
donepezil
Prior art date
Application number
PT158703652T
Other languages
English (en)
Original Assignee
Icure Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Icure Pharm Inc filed Critical Icure Pharm Inc
Publication of PT3235494T publication Critical patent/PT3235494T/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT158703652T 2014-12-18 2015-12-18 Preparação transdérmica contendo donepezilo como ingrediente ativo PT3235494T (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR20140183446 2014-12-18

Publications (1)

Publication Number Publication Date
PT3235494T true PT3235494T (pt) 2020-03-05

Family

ID=56126987

Family Applications (1)

Application Number Title Priority Date Filing Date
PT158703652T PT3235494T (pt) 2014-12-18 2015-12-18 Preparação transdérmica contendo donepezilo como ingrediente ativo

Country Status (15)

Country Link
US (1) US10888533B2 (pt)
EP (1) EP3235494B1 (pt)
JP (1) JP6793648B2 (pt)
KR (1) KR101796771B1 (pt)
CN (2) CN113797180A (pt)
AU (1) AU2015363883B2 (pt)
CA (1) CA2970276C (pt)
DK (1) DK3235494T3 (pt)
ES (1) ES2786399T3 (pt)
HU (1) HUE048569T2 (pt)
MY (1) MY181540A (pt)
PL (1) PL3235494T3 (pt)
PT (1) PT3235494T (pt)
RU (1) RU2713207C2 (pt)
WO (1) WO2016099198A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201805570WA (en) 2015-12-30 2018-07-30 Corium Int Inc Systems and methods for long term transdermal administration
JP7174632B2 (ja) 2016-06-23 2022-11-17 コリウム， インコーポレイテッド 親水性ドメインおよび疎水性ドメインならびに処置剤との接着剤マトリックス
MX2019001104A (es) 2016-07-27 2019-10-02 Corium Int Inc Sistemas de suministro transdermico de memantina.
US20180028461A1 (en) 2016-07-27 2018-02-01 Corium International, Inc. Transdermal delivery systems with pharmacokinetics bioequivalent to oral delivery
EP3490541A2 (en) 2016-07-27 2019-06-05 Corium International, Inc. Transdermal formulation and delivery method of low solubility or unstable unionized neutral drugs byin situ
KR102033686B1 (ko) 2017-05-19 2019-10-18 보령제약 주식회사 도네페질을 함유하는 마이크로니들 경피 패치
JP2020529229A (ja) * 2017-07-26 2020-10-08 コリウム， インコーポレイテッド 溶媒充填細孔を有する微多孔膜を有する経皮送達システム
WO2019126531A1 (en) 2017-12-20 2019-06-27 Corium, Inc. Transdermal adhesive composition comprising a volatile liquid therapeutic agent having low melting point
KR102024996B1 (ko) * 2017-12-27 2019-09-25 동아에스티 주식회사 도네페질을 함유하는 치매 치료용 경피흡수제제
KR102115102B1 (ko) * 2018-12-21 2020-05-26 동아에스티 주식회사 안정화된 도네페질 함유 경피 흡수제제
KR20230056268A (ko) 2021-10-20 2023-04-27 서울대학교병원 치매 약물의 부작용을 평가할 수 있는 치매 약물 패치

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5985317A (en) * 1996-09-06 1999-11-16 Theratech, Inc. Pressure sensitive adhesive matrix patches for transdermal delivery of salts of pharmaceutical agents
JP3987655B2 (ja) 1998-03-03 2007-10-10 エーザイ・アール・アンド・ディー・マネジメント株式会社 抗痴呆薬を含有した経皮適用製剤又は坐剤
WO2002069942A1 (fr) * 2001-03-07 2002-09-12 Hisamitsu Pharmaceutical Co., Inc. Timbre adhesif
EP1437130A4 (en) 2001-10-17 2009-08-26 Hisamitsu Pharmaceutical Co PERCUTANEOUS ABSORPTION PREPARATIONS
US20100048628A1 (en) * 2006-12-01 2010-02-25 Sumiyo Nishi Method for suppressing discoloration over time of adhesive preparation containing donepezil
KR101454362B1 (ko) * 2008-03-24 2014-10-23 아이큐어 주식회사 도네페질을 유효성분으로 함유하는 치매 치료용경피흡수제제
US20090291127A1 (en) * 2008-05-21 2009-11-26 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
US20100080842A1 (en) * 2008-09-30 2010-04-01 Jianye Wen Transdermal extended-delivery donepezil compositions and methods for using the same
US8456368B2 (en) * 2009-01-27 2013-06-04 Casio Computer Co., Ltd. Antenna device and radio-wave receiver with such antenna device
US20100209484A1 (en) * 2009-02-13 2010-08-19 Hoo-Kyun Choi Transdermal Triptan Delivery System
WO2011034323A2 (en) * 2009-09-16 2011-03-24 Samyang Corporation Transdermal delivery system, method for manufacturing the same, and transdermal delivery method using the system
JP2012236773A (ja) * 2009-12-16 2012-12-06 Goto Takeshi 抗認知症薬物の経皮吸収製剤
US20100178307A1 (en) * 2010-01-13 2010-07-15 Jianye Wen Transdermal anti-dementia active agent formulations and methods for using the same
NZ605352A (en) * 2010-06-30 2013-10-25 Nal Pharmaceuticals Ltd Process for producing glycosaminoglycans
TWI433904B (zh) * 2011-01-12 2014-04-11 Taiwan Biotech Co Ltd 多奈哌齊經皮貼片
KR101395557B1 (ko) * 2011-08-25 2014-05-16 아이큐어 주식회사 경피 흡수 제제 및 그 제조방법
KR101239150B1 (ko) * 2012-02-28 2013-03-06 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
US9539201B2 (en) * 2012-04-20 2017-01-10 KAT Transdermals LLC Selegiline transdermal system
CN102895217A (zh) * 2012-11-13 2013-01-30 沈阳药科大学 长效多奈哌齐经皮吸收贴剂
KR101770675B1 (ko) * 2013-01-30 2017-08-23 에스케이케미칼주식회사 도네페질-함유 경피흡수제제 및 그의 제조방법
CN108123793A (zh) * 2017-12-19 2018-06-05 杭州中天微系统有限公司 基于apb总线的spi通信装置

Also Published As

Publication number Publication date
DK3235494T3 (da) 2020-03-02
RU2017125361A3 (pt) 2019-07-17
RU2017125361A (ru) 2019-01-18
KR101796771B1 (ko) 2017-11-10
HUE048569T2 (hu) 2020-07-28
WO2016099198A1 (ko) 2016-06-23
RU2713207C2 (ru) 2020-02-04
AU2015363883A1 (en) 2017-06-29
CA2970276A1 (en) 2016-06-23
AU2015363883B2 (en) 2021-03-25
CN113797180A (zh) 2021-12-17
MY181540A (en) 2020-12-28
PL3235494T3 (pl) 2020-08-24
CN107106510A (zh) 2017-08-29
CA2970276C (en) 2023-08-01
JP6793648B2 (ja) 2020-12-02
EP3235494A1 (en) 2017-10-25
US10888533B2 (en) 2021-01-12
BR112017012951A2 (pt) 2018-03-06
KR20160074433A (ko) 2016-06-28
ES2786399T3 (es) 2020-10-09
US20170290780A1 (en) 2017-10-12
EP3235494B1 (en) 2019-11-27
JP2017538771A (ja) 2017-12-28
EP3235494A4 (en) 2018-08-15

Similar Documents

Publication Publication Date Title
HK1245625A1 (zh) 用於經皮施用的方法和製劑
IL252550A0 (en) Cannabinoid compounds through the skin
HUE048569T2 (hu) Hatóanyagként donepezilt tartalmazó transzdermális készítmény
IL248984A0 (en) Transdermal cream
IL247427A0 (en) A chemical agricultural preparation for the treatment of plants
IL252062A0 (en) Transdermal compositions
GB201516729D0 (en) Liquid nicotine formulation
EP3096745A4 (en) Transdermal delivery system comprising donepezil or its salt
SG11201702298VA (en) Pharmaceutical preparation
IL251059B (en) Arimoclomol formulation
IL273087A (en) Transdermal compositions
HK1243927A1 (zh) 含有茶皂醇衍生物作爲活性成分的組合物
SG11201610636VA (en) Pharmaceutical preparation containing entecavir as active ingredient, and preparation method therefor
IL249010A0 (en) A pharmaceutical preparation containing a pyrazine carboxamide compound as an active ingredient
SG11201608845PA (en) Cosmetic composition containing mentha haplocalyx as active ingredient
PL3184492T3 (pl) Preparat antyseptyczny
EP3107532A4 (en) Transdermal drug delivery system containing donepezil
EP3181125A4 (en) Capsule formulation
IL258295A (en) Fviii formulation
EP3150205A4 (en) Transdermal preparation
EP3100721A4 (en) Capsule formulation
ZA201500995B (en) Low dose pharmaceutical composition
GB201417589D0 (en) Pharmaceutical Formulations
IL258675A (en) Mosquito repellent compounds
EP3299012A4 (en) Transdermal liquid preparation